From a wide variety of energy policy perspectives – be it reliability, affordability, security or redundancy – we will continue to need not just electrons but also molecules to […]

 Fewer new drugs for rare disorders come to Canada relative to the US and Europe. Canada has set-up barriers that delay or deny access to new drugs for many […]

 On October 13th, 2023, the Supreme Court of Canada, in a 5-2 decision, held that the majority of the Impact Assessment Act was outside Parliament’s law-making authority and thus […]